Celcuity (CELC) Non Operating Income (2016 - 2025)
Celcuity (CELC) reported Non Operating Income of -$1.8 million for Q4 2025, down 694.62% on a YoY basis from $298006.0 in Q4 2024, and down 85.55% quarter-over-quarter from -$955000.0 in Q3 2025.
Celcuity (CELC) Non Operating Income (2016 - 2025) Analysis & Trends
Celcuity has reported Non Operating Income for 10 years, with the latest figure at -$1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 694.62% year-over-year to -$1.8 million; the trailing twelve-month figure through Dec 2025 stood at -$4.8 million (down 425.94% YoY), and the FY2025 full-year result was -$4.8 million, down 425.94% from the prior year.
- Non Operating Income for Q4 2025 stood at -$1.8 million, down from -$955000.0 in the prior quarter.
- The five-year high for Non Operating Income was $881000.0 in Q1 2024, with the low at -$1.8 million in Q4 2025.
- Historically, Non Operating Income has averaged -$156954.2 across 5 years, with a median of -$236583.0 in 2022.
- Annual changes were most pronounced in 2022 — Non Operating Income tumbled 418572.55% — and 2023, when it jumped 1422.35%.
- Celcuity's Non Operating Income stood at -$432608.0 in 2021, then jumped by 113.37% to $57858.0 in 2022, then jumped by 1422.35% to $880800.0 in 2023, then plunged by 125.32% to -$223000.0 in 2024, then sank by 694.62% to -$1.8 million in 2025.
- The last three Non Operating Income figures came in at -$1.8 million (Q4 2025), -$955000.0 (Q3 2025), and -$1.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 9.35 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | -955,000.00 |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | -864,000.00 |
| Dec 31, 2024 | -223,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 562,000.00 |
| Mar 31, 2024 | 881,000.00 |
| Dec 31, 2023 | 880,800.00 |
| Sep 30, 2023 | 493,497.00 |
| Jun 30, 2023 | 467,798.00 |
| Mar 31, 2023 | 609,120.00 |
| Dec 31, 2022 | 57,858.00 |
| Sep 30, 2022 | -250,166.00 |
| Jun 30, 2022 | -359,799.00 |
| Mar 31, 2022 | -426,842.00 |
| Dec 31, 2021 | -432,608.00 |
| Sep 30, 2021 | -427,460.00 |
| Jun 30, 2021 | -389,384.00 |
| Mar 31, 2021 | 102.00 |